SXT SENSIENT TECHNOLOGIES CORP
Industrial Organic Chemicals · NYSE · SEC CIK 310142 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.5%
TTM net income YoY21.7%
TTM EPS YoY21.4%
Revenue 3-yr CAGR6.3%
Net income 3-yr CAGR9.7%
Margins
Gross margin35.1%
Operating margin14.5%
Net margin9.7%
FCF margin-1.0%
EBITDA margin18.1%
Returns
ROE13.7%
ROA7.2%
ROIC (approx.)10.0%
Asset turnover0.75x
Leverage & solvency
Liabilities / assets48.0%
Debt / equity0.61x
Current ratio3.97x
Interest coverage7.95x
Cash quality & payout
Operating cash flow / net income0.71x
Accruals ratio2.1%
Payout ratio41.2%
Capex / revenue7.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $455.84M | $462.08M | $435.83M | $393.45M | $412.11M | $414.23M | $392.32M | $376.42M |
| Cost of revenue | $290.89M | $289.28M | $283.15M | $270.10M | $270.77M | $271.40M | $260.55M | $257.00M |
| Gross profit | $164.95M | $172.80M | $152.69M | $123.35M | $141.34M | $142.83M | $131.78M | $119.42M |
| SG&A expense | $92.50M | $96.10M | $85.96M | $85.16M | $83.64M | $85.13M | $78.25M | $77.42M |
| Operating income | $72.45M | $76.70M | $66.73M | $38.19M | $57.71M | $57.71M | $53.53M | $42.00M |
| Interest expense | $8.35M | $8.17M | $7.90M | $7.52M | $7.33M | $7.39M | $7.34M | $6.39M |
| Pretax income | $64.10M | $68.53M | $58.83M | $30.66M | $50.38M | $50.31M | $46.19M | $35.61M |
| Income tax | $15.76M | $17.17M | $14.66M | $5.18M | $13.42M | $12.73M | $11.73M | $5.50M |
| Net income | $48.34M | $51.36M | $44.17M | $25.48M | $36.96M | $37.59M | $34.46M | $30.10M |
| EBITDA | $88.70M | $92.59M | $82.27M | $53.39M | $73.26M | $72.97M | $68.60M | $57.14M |
| EPS (basic) | 1.14 | 1.21 | 1.04 | — | 0.87 | 0.89 | 0.82 | — |
| EPS (diluted) | 1.13 | 1.20 | 1.04 | — | 0.87 | 0.88 | 0.81 | — |
| Dividends declared per share | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
| Weighted avg. shares (diluted) | 42.83M | 42.76M | 42.67M | — | 42.66M | 42.58M | 42.47M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $42.62M | $31.02M | $38.54M | $36.53M | $42.67M | $56.69M | $32.57M | $26.63M |
| Receivables | $373.75M | $376.50M | $342.30M | $305.38M | $323.39M | $333.95M | $315.02M | $290.09M |
| Inventory | $791.10M | $719.09M | $681.73M | $678.22M | $653.72M | $619.60M | $598.20M | $600.30M |
| Current assets | $1.28B | $1.18B | $1.12B | $1.08B | $1.07B | $1.07B | $1.00B | $961.89M |
| PP&E, net | $606.43M | $574.71M | $550.55M | $539.30M | $518.49M | $515.47M | $499.18M | $491.59M |
| Goodwill | $433.59M | $435.06M | $436.39M | $439.71M | $439.44M | $441.01M | $424.23M | $411.77M |
| Intangibles | $9.43M | $9.54M | $9.89M | $10.12M | $10.46M | $10.93M | $11.45M | $11.88M |
| Total assets | $2.48B | $2.37B | $2.29B | $2.24B | $2.21B | $2.20B | $2.09B | $2.02B |
| Current liabilities | $323.01M | $269.62M | $223.71M | $263.58M | $233.69M | $251.12M | $230.69M | $270.64M |
| Short-term debt | $257,000 | $397,000 | $232,000 | $352,000 | $777,000 | $26.28M | $18.57M | $19.85M |
| Long-term debt | $790.15M | $763.50M | $767.56M | $709.23M | $711.18M | $710.12M | $683.27M | $613.52M |
| Total debt | $790.40M | $763.90M | $767.79M | $709.58M | $711.95M | $736.40M | $701.84M | $633.37M |
| Total liabilities | $1.19B | $1.11B | $1.07B | $1.05B | $1.03B | $1.05B | $997.63M | $962.81M |
| Shareholders' equity | $1.29B | $1.26B | $1.22B | $1.19B | $1.18B | $1.16B | $1.10B | $1.06B |
| Net debt | $747.78M | $732.88M | $729.25M | $673.05M | $669.28M | $679.71M | $669.27M | $606.75M |
| Cash flow statement | ||||||||
| Operating cash flow | $40.47M | $48.46M | -$13.62M | $44.56M | $43.96M | $48.28M | -$8.98M | $21.39M |
| Capital expenditure | $38.26M | $38.78M | $28.74M | $31.62M | $19.75M | $21.18M | $16.85M | $23.12M |
| Free cash flow | $2.21M | $9.69M | -$42.35M | $12.94M | $24.21M | $27.10M | -$25.83M | -$1.73M |
| Investing cash flow | -$38.50M | -$38.85M | -$26.92M | -$31.68M | -$19.51M | -$20.21M | -$21.28M | -$22.02M |
| Financing cash flow | $11.48M | -$18.86M | $42.40M | -$21.15M | -$39.88M | -$9.97M | $35.96M | -$6.41M |
| Depreciation & amortization | $16.25M | $15.89M | $15.54M | $15.21M | $15.56M | $15.26M | $15.07M | $15.14M |
| Stock-based compensation | $4.38M | $5.60M | $3.78M | $3.36M | $3.94M | $3.74M | $2.90M | $3.10M |
| Dividends paid | $17.45M | $17.44M | $17.43M | $17.42M | $17.50M | $17.32M | $17.38M | $17.36M |
Free plan shows the latest 8 periods; Pro shows all 70 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.